NEW ORLEANS, March 23, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 8, 2018 to file lead plaintiff applications in a securities class action lawsuit against Foot Locker, Inc. (NYSE:FL), if they purchased the Company’s shares between August 19, 2016 and August 17, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Foot Locker investors should visit us at https://www.claimsfiler.com/cases/view-foot-locker-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Foot Locker and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 18, 2017, the Company revealed negative financial results for the second quarter of fiscal year 2017, including revenue significantly below expectations, attributed in part to lower same-store sales, that many more stores were being closed than previously announced, and that weaker sales were expected for the rest of the fiscal year.
On this news, the price of Foot Locker’s shares plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



